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The present study investigated the hypolipidaemic effects of Grifola frondosa and its
regulation mechanism involved in lipid metabolism in liver of rats fed a high-cholesterol
diet. The body weights and serum lipid levels of control rats, of hyperlipidaemic rats,
and of hyperlipidaemic rats treated with oral G. frondosa were determined. mRNA
expression and concentration of key lipid metabolism enzymes were investigated. Serum
cholesterol, triacylglycerol, and low-density lipoprotein cholesterol levels were markedly
decreased in hyperlipidaemic rats treated with G. frondosa compared with untreated
hyperlipidaemic rats. mRNA expression of 3-hydroxy-3-methylglutaryl-CoA reductase
(HMGCR), acyl-coenzyme A: cholesterol acyltransferase (ACAT2), apolipoprotein
B (ApoB), fatty acid synthase (FAS), and acetyl-CoA carboxylase (ACC1) were
significantly down-regulated, while expression of cholesterol 7-alpha-hydroxylase
(CYP7A1) was significantly up-regulated in the livers of treated rats compared with
untreated hyperlipidaemic rats. The concentrations of these enzymes also paralleled
the observed changes in mRNA expression. Two-dimensional polyacrylamide gel
electrophoresis (2-DE) and Matrix-Assisted Laser Desorption/Ionization Time of Flight
Mass Spectrometry (MALDI-TOF-MS) were used to identify 20 proteins differentially
expressed in livers of rats treated with G. frondosa compared with untreated
hyperlipidemic rats. Of these 20 proteins, seven proteins were down-regulated, and
13 proteins were up-regulated. These findings indicate that the hypolipidaemic effects
of G. frondosa reflected its modulation of key enzymes involved in cholesterol and
triacylglycerol biosynthesis, absorption, and catabolic pathways. G. frondosa may exert
anti-atherosclerotic effects by inhibiting LDL oxidation through down-regulation and
up-regulating proteins expression in the liver of rats. Therefore,G. frondosamay produce
both hypolipidaemic and anti-atherosclerotic effects, and potentially be of use as a
functional food for the treatment or prevention of hyperlipidaemia and atherosclerosis.
Keywords: Grifola frondosa, hyperlipidaemia, lipid metabolism, gene expression, two-dimensional
electrophoresis, proteomics
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INTRODUCTION
Hyperlipidaemia is a metabolic disorder with a high global
prevalence characterized by elevated circulating levels of total
cholesterol (TC), low-density lipoprotein cholesterol (LDL-C),
and triacylglycerols (TG), with a reduced concentration of high-
density lipoprotein cholesterol (HDL-C) in the blood (Hongli
et al., 2013). Hyperlipidaemia is a primary risk factor for
the development of atherosclerosis, coronary heart disease,
peripheral artery diseases, and other major metabolic diseases
(Watts and Fredrik, 2011). It has been reported that even 1%
reduce in the serum TC levels was estimated to result in 2–3%
decrease in the risk of cardiovascular disease (Catapano et al.,
2000). Therefore, the reduction of circulating TC and LDL-C
levels are important strategy that can be employed to prevent or
slow the progression of atherosclerosis (Hansson, 2005). Normal
physiological functions can be maintained by decreasing elevated
serum TC to an appropriate level. Research into functional
foods has identified plants and fungi with beneficial effects
in certain diseases (Mélanie and Jones, 2004); for example,
a novel functional diet formulation of Auricularia auricula
and Chinese hawthorn (Crataegus pinnatifida) showed effective
hypolipidaemic properties (Luo et al., 2009). A large number of
bioactive components of foods have been reported to potentially
produce hypolipidaemic effects. These findings have intensified
the search for foods that lower serum lipid levels effectively with
minimum side effects (Liu et al., 2014).
Grifola frondosa is a promising candidate with lipids-lowering
effects that may prevent atherosclerotic disease through its
high fiber, microelement, protein, and polysaccharide content
(Gu et al., 2007). G. frondosa, also known as Maitake, is a
basidiomycete polypore fungus belonging to the Meripilaceae
family (Shin and Lee, 2014).G. frondosa is amedicinalmushroom
in traditional Chinese and Japanese herbology, as well as
being widely used is an edible mushroom for cooking, and
dietary supplementation in Asia. This fungus has shown various
biological activities, including antitumor (Kodama et al., 2003),
immuno-modulatory (Gary et al., 2009), hypotensive (Talpur
et al., 2002), and antioxidant effects. Recently, an antioxidant
polysaccharide was purified from G. frondosa (Chen et al.,
2012), and our laboratory has previously demonstrated that G.
frondosa polysaccharides produced hypoglycaemic effects in a
mouse model of type 2 diabetes (Xiao et al., 2011). Therefore,
G. frondosa can be considered to have potential as a functional
Abbreviations: TC, total cholesterol; TG, triacylglycerol; LDL-C, low-
density lipoprotein-cholesterol; HDL-C, high-density lipoprotein-cholesterol;
HMGCR, 3-hydroxy-3-methylglutaryl-CoA reductase; ACAT2, acyl-Coenzyme
A: cholesterol acyltransferase; CYP7A1, Cholesterol 7-alpha-hydroxylase,
Cytochrome P450, family 7, subfamily a, polypeptide 1; ApoB, apolipoprotein B;
FAS, fatty acid synthase; ACC1, Acetyl-CoA carboxylase; HMGCS2, 3-hydroxyl-
3-methylglutaryl-CoA synthase 2; HMGC, 3-hydroxy-3-methylglutaryl-CoA;
ACSL1, long-chain-fatty-acid–CoA ligase 1; HSPD1, 60 kDa heat shock protein;
CPPED1, serine/threonine-protein phosphatase; AMACR, alpha-methylacyl-
CoA racemase; Prdx-1, Peroxiredoxin-1; SOD, Superoxide dismutase; HPX,
Haemopexin; RT-PCR, real-time PCR; GAPDH, Glyceraldehyde-3-phosphate
dehydrogenase; 2-DE, two-dimensional polyacrylamide gel electrophoresis;
MALDI-TOF-MS, Matrix-Assisted Laser Desorption/ Ionization Time of Flight
Mass Spectrometry.
food. The hypolipidaemic effects of G. frondosa were previously
reported that it reduced serum lipid levels by promoting the
conversion of cholesterol to bile acid (Kubo and Nanba, 1997).
Subsequent investigations (Fukushima et al., 2001) showed that
G. frondosa fiber significantly reduced serum lipid levels by
enhancing fecal cholesterol excretion. Another study (Mayumi
et al., 2013) also revealed that G. frondosa reduced serum
lipid levels. However, few studies have investigated whether G.
frondosa can regulate the expression of key genes involved in lipid
metabolism.
Hepatic cholesterol metabolism is an important physiological
process involved in lipid metabolic disorder (Li et al., 2014).
Cholesterol homeostasis is regulated by coordinated changes in
cholesterol biosynthesis, absorption, catabolism, and transport of
lipoprotein particles. HMGCR is a key rate-limiting enzyme for
de novo cholesterol synthesis. ACAT2 is a key tissue cholesterol-
esterifying enzyme that plays an key role in cholesterol
absorption by catalyzing the formation of cholesterol esters from
cholesterol and long-chain fatty acids in vivo in response to
excess intracellular cholesterol (Lee et al., 2005). CYP7A1 is a key
rate-limiting enzyme for bile acid biosynthesis from cholesterol
(Hubacek and Bobkova, 2006). Approximately 95% of LDL is
ApoB, which is constitutively expressed in the liver. ACC1 is a key
enzymes in the synthesis of fatty acids and triacylglycerol in the
liver. And few research has been carried out concerning whether
the lipid-lowering effects ofG. frondosa are regulated by these key
genes. Therefore, this study was undertaken to assess the lipid-
lowering effects of G. frondosa and its regulation mechanism
on key genes involved in lipid metabolism in liver of rat, i.e.,
HMGCR, ACAT2, ApoB, CYP7A1, FAS, and ACC1.
MATERIALS AND METHODS
Sample Preparation
Dried G. frondosa fruiting bodies were obtained from
Guangdong Yuewei Edible Fungi Technology Co. Ltd
(Guangzhou, China). After drying with hot air at 40◦C for
3 h, the dehydrated fruiting bodies were milled to a powder with
a particle size of ∼0.3mm using a grinding and mixing machine
(BFM-6A; Ji’nan Supertime Technology Co. Ltd, Jinan, China).
The dried G. frondosa fruiting body powder was reconstituted in
purified water at a ratio of 1:13 (w/v). A dose of 760mg/kg body
weight administered to rats based on our laboratory health care
product studies of the hypolipidaemic effect of A. auricular.
Animals, Diets, and Hyperlipidaemia
Thirty male 8-week-old specific pathogen-free Sprague-
Dawley rats (weighing 200 ± 20 g) were purchased from
Guangdong Medical Laboratory Animal Center, Guangzhou,
China (production certificate no. scxk [Yue] 2011-0015; quality
certificate no. 44002100002251; Experimental Animals License
no. syxk [Yue] 2013-0011). The rats were housed individually
in stainless steel cages in a specific pathogen-free room at a
controlled temperature (22 ± 2◦C) with relative humidity of
55± 5% and a 12 h cycle of light and dark. All animal procedures
complied with the Guide for the Care and Use of Laboratory
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Animals and were approved by the Animal Care Committee
of the Center for Disease Control and Prevention (Guangdong
Province, China).
After acclimatization for 7 days, the rats were randomly
divided into two groups: a control group (n = 10)
and a hyperlipidaemic group (n = 20). Control rats
were provided with a basal diet (quality certificate no.
4420030005388) and the hyperlipidaemic group was provided
with a hypercholesterolaemic diet (quality certificate no.
4420030000055). The basal diet consisted of 33.64% corn, 22.5%
bran, 17% flour, 17.5% soybean meal, 1.33% soybean oil, 4%
fish meal, 1% powder, 2% dicalcium phosphate, 1% additive,
and 0.03% choline. The hypercholesterolaemic diet consisted of
52.2% basal diet, 1.2% cholesterol, 20% sucrose, 15% lard oil,
10% casein, 0.6% calcium bicarbonate, 0.2% sodium cholate,
0.4% mountain flour, and 0.4% premix.
After 2 weeks, a blood sample was collected from the tail
vein of each rat and assayed for serum TC levels using a Hitachi
7060 automatic biochemical analyzer (Hitachi Limited, Tokyo,
Japan). Serum TC levels were markedly elevated (P < 0.05) in
the hyperlipidaemic group compared with the control group.
All 20 rats receiving the hypercholesterolaemic diet for 2 weeks
exhibited hyperlipidaemia. The hyperlipidaemic rats were then
randomly divided into two groups: a hyperlipidaemic group and
a G. frondosa group.
The control rats continued to receive basal diet and were
orally administered with distilled water at the same time every
morning for 5 weeks. The hyperlipidaemic group received the
hypercholesterolaemic diet and were orally administered with
distilled water at the same time everymorning for 5 weeks. TheG.
frondosa group received the hypercholesterolaemic diet and were
orally administered with 760 mg/kg body weight G. frondosa at
the same time every morning for 5 weeks.
Sampling
At the end of the experimental period, all rats were sacrificed
(without fasting). Blood samples were collected into heparinized
tubes using a disposable plastic syringe and left at room
temperature to coagulate for 20 min. Serum was obtained
by centrifugation at 3000 g for 10 min at 4◦C and stored
at −70◦C until use. Livers were removed, washed with
normal saline, and blotted dry on filter paper before snap-
freezing in liquid nitrogen and storage at −70◦C until further
analysis.
Serum Biochemical Analysis
Serum levels of TC, TG, LDL-C, and HDL-C were determined
using the Hitachi 7060 automatic biochemical analyser and
commercial assay kits (Bio Sino Bio-technology and Science Inc),
according to the manufacturer’s instructions.
Enzymatic Concentration Assay
The enzymatic concentrations of HMGCR, ACAT2, CYP7A1,
ApoB, FAS, and ACC1 in rat liver samples were determined using
appropriate rat enzyme-linked immunosorbent assay (ELISA)
kits (Westan Biotech Co), according to the manufacturer’s
instructions, and using a Thermo Scientific microplate reader
(Multiskan Go).
RNA Preparation, cDNA Synthesis, and
Quantitative Real-time PCR (RT-PCR)
Total RNA was prepared using RNAiso Plus (Takara, code no.
9108) according to the manufacturer’s protocol. Total RNA was
transcribed into cDNA using a Prime Script TM RT Master
Mix (Takara, code no. RR036A) according to the manufacturer’s
instructions. RT-PCR was carried out on a Master cycle Rep
Realplex RT-PCR system (Eppendorf, Germany) using SYBR
Premix Ex Taq (Tli RNase H Plus; Takara, Code No. RR420A) to
determine the expression of HMGCR, ACAT2, ApoB, CYP7A1,
FAS, and ACC in rat liver tissue. Glyceraldehyde-3-phosphate
dehydrogenase (GAPDH) was used as an internal control. The
primers for RT-PCR are presented in Table 1. PCR was carried
out in duplicate by incubating the reaction mix at 95◦C for 2 min
followed by 40 cycles of 95◦C for 15 s, 60◦C for 20 s, and 72◦C for
30 s. The relative levels of target mRNAs were determined using
the 2−11Ct method and were normalized to the GAPDHmRNA
signals in each sample.
Protein Preparation, 2-DE, and Protein
Identification
Rat livers were individually pulverized in liquid nitrogen and
dissolved in 1 ml alklysis buffer containing 40 mM Tris base, 7
M urea, 2 M thiourea, 4% CHAPs, 65 mM dithiothreitol, and
2% IPG buffer. The solution was centrifuged at 12,000 rpm for
10 min at 4◦C and supernatant was purified using a Ready Prep
2-D Clean-up Kit (catalog no. 163-2130, BioRad) according to
the manufacturer’s protocol. A non-interference protein assay kit
(Sang on Biotech Co. Ltd, SK3071) was used to determine the
protein concentrations.
TABLE 1 | SYBR green primer sequences used for RT-PCR.
Gene Accession No. Forward primers (5′ to 3′) Reverse primers (5′ to 3′) Size(bp)
GAPDH NM017008.4 CCGCATCTTCTTGTGCAGTG TCCCGTTGATGACCAGCTTC 250
HMGCR XM006231826.1 GAGCGTTCGTGGGTCCAG GGCACAACCTGCCGTATCTA 242
ACAT2 NM_153728.2 GAACGTGGTGGTCCATGACT TTCAGCAGACCTCCAACCAC 201
CYP7A1 NM_012942.2 TGGAGAACGGGTTGATTCCG CTGTGTCCAAATGCCTTCGC 235
ApoB NM019287.2 AGCTGATCGAAGTGTCCAGC TGTTAACCGCATGGCTCAGT 246
FAS NM017332.1 CCACAGGACAAGCCCATCTT TCGGAGACAGTTCACCAAGC 159
ACC1 NM022193.1 ACAACGCAGGCATCAGAAGA GCTGTGCTGCAGGAAGATTG 245
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Protein samples (800 µg) were mixed with rehydration
buffer (containing IPG buffer, pH 4–7) and passively rehydrated
overnight (12–16 h) at ambient temperature. In the first-
dimension isoelectric focusing phase, proteins were focused
sequentially at 100 V for 30min, 250V for 1 h, 1000V for 2 h,
4000V for 2 h, 10,000V for 3 h, 60,000V. h and finally kept
at 500V. The strips were equilibrated twice for 15min in the
first and second equilibration buffers and transferred onto a 12%
polyacrylamide gel for second-dimension electrophoresis, which
was performed at 100V, 30A for 30 min followed by 200V, 150A
for 8 h. All gels were then silver-stained.
The stained 2-DE gels were scanned using the Image Master
2D platinum 5.0 software (GE Healthcare China, Guangzhou),
which was also used to match and analyze the images. Spots with
a ≥1.5-fold change in intensity were analyzed to determine the
statistical significance of any differences in protein expression
between the study groups. The protein spots of interest
were excised from the gels and washed twice with MilliQ
water. The gel slices were digested at 37◦C overnight (16 h)
with sequencing grade modified trypsin. The digested samples
were identified using MALDI-TOF-MS. Protein identification
was conducted using Mascot software and the Uniprot rat
data base. The differential proteins were then loaded to the
Kyoto Encyclopedia of Genes and Genomes (KEGG) Mapper
(www.genome.jp/kegg/), and an in-house Perl script was used to
identify pathway over-representation.
Statistical Analysis
All results are expressed as the mean ± standard deviation
(SD). Differences between groups were determined by one-way
ANOVA. Statistical differences were considered significant at
P < 0.05. SPSS software version 21.0 was used for all analyses.
RESULTS
Effect of Grifola frondosa on Body Weight
Rat body weight data are shown in Figure 1. After
acclimatization for 1 week and the establishment of
hyperlipidemic for another 2 weeks, there were no significant
differences in body weight observed between the control,
hyperlipidemic, and G. frondosa groups. At the end of the
experiment (7 weeks), the results indicated that hyperlipidemic
rats significantly increased in body weight compared with the
control group (∗P < 0.05), but no significant differences in body
weight gain were observed between the hyperlipidemic and G.
frondosa groups.
Effects of Grifola frondosa on Rat Serum
Lipid Levels
As summarized in Figure 2, serum TG, TC, and LDL-C levels
were markedly elevated in hyperlipidaemic rats compared
with the control group. Administration of G. frondosa led to
significant reductions in serum TG, TC, and LDL-C levels
compared with those of the hyperlipidaemic group, indicating
the beneficial effects of G. frondosa treatment on serum lipid
profiles in hyperlipidemic rats.
FIGURE 1 | Effect of Grifola frondosa on body weight (*P < 0.05,
control group vs. hyperlipidemic group).
FIGURE 2 | Effects of Grifola frondosa on serum lipid levels of rats
(*P < 0.05, **P < 0.01, control group vs. hyperlipidemic group;
#P < 0.05, ##P < 0.01, G. frondosa group vs. hyperlipidemic group).
Effects of Grifola frondosa on Rat Liver
Expression of Key Genes Involved in Lipid
Metabolism
RT-PCR data (Figure 3) showed that liver HMGCR, ACAT2,
ApoB, and FAS mRNA expression levels were elevated in
hyperlipidaemic rats compared with the control group, but
were markedly decreased in hyperlipidaemic rats treated
with G. frondosa. Although ACC1 gene expression was not
up-regulated in hyperlipidaemic rat liver compared with the
control group, it was significantly reduced in hyperlipidaemic
rats treated with G. frondosa. In contrast, liver CYP7A1
gene expression was down-regulated in hyperlipidaemic
rats compared with the control group, but significantly
increased in hyperlipidaemic rats following G. frondosa
administration.
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Effects of Grifola frondosa on the
Concentration of Key Enzymes Involved in
Lipid Metabolism in Rat Liver
The ELISA data (Table 2) showed that same trends in liver
concentrations of HMGCR, ACAT2, ApoB, CYP7A1, and FAS
enzymes reflected the expression of their respective mRNAs.
Notably, liver ACC1 enzyme concentration was significantly
increased in hyperlipidaemic rats compared with the control
group, but significantly reduced in rats treated with G. frondosa.
2-DE Image and Protein Identification by
MALDI-TOF-MS
Figure 4 shows the 2-DE images obtained from rat liver protein
extracts and illustrates the locations of differentially expressed
spots. Approximately 1400 protein spots were identified on
the 4–7 NL range gels by silver staining. Spots with a ≥1.5-
fold change in intensity were analyzed. Differential analysis
showed that 98 spots were up-regulated in the control group
compared with the hyperlipidaemic group and 80 spots were
up-regulated in the G. frondosa group compared with the
hyperlipidaemic group. Twenty-three repeat spots were present
FIGURE 3 | Effects of Grifola frondosa on mRNA expression of key
genes in rat liver (*P < 0.05, **P < 0.01, control group vs.
hyperlipidemic group; #P < 0.05, ##P < 0.01, G. frondosa group vs.
hyperlipidemic group).
TABLE 2 | Effects of Grifola frondosa on enzymatic concentration of rat
liver.
Enzyme Control Hyperlipidemia Grifola frondosa
HMGCR(U/L) 4.73± 1.55 14.56±0.23** 10.68± 0.26##
ACAT2(U/L) 56.81± 10.84 155.41±9.90** 89.16± 12.39##
ApoB(µg/ml) 551.22± 85.24 1007.95±73.21** 732.89± 85.00##
CYP7A1(U/L) 47.32± 1.58 20.13±3.85** 35.97± 1.26#
FAS (nmol/L) 7.06± 0.69 16.28±0.88** 13.15± 0.51##
ACC1 (pmol/L) 393.29± 23.58 774.48±29.36** 575.09± 18.52##
**P < 0.01, control group vs. hyperlipidemic group; #P < 0.05, ##P < 0.01, Grifola
frondosa group vs. hyperlipidemic group.
FIGURE 4 | 2-DE images from rat liver protein extracts (proteins were
separated in the first dimension at pH 4.0–7.0 and on a 12% SDS-PAGE
gel in the second dimension. (A) Control group. (B) Hyperlipidemic group.
(C) Grifola frondosa group).
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in both of these differentially regulated groups. Furthermore, 59
spots were down-regulated in the control group compared with
the hyperlipidaemic group and 74 spots were down-regulated
in the G. frondosa group compared with the hyperlipidaemic
group. 17 repeat spots were present in both of these differentially
regulated groups. Therefore, these 40 (23 + 17) repeat protein
spots were chosen for analysis by MALDI-TOF-MS and 20 of
these were identified (Figure 4 and Table 3).
The 20 differentially expressed proteins were identified by
searching the Mascot Uniprot rat database for the peptide mass
fingerprint. Eight of which were relevant to lipid metabolism.
3-hydroxyl-3-methylglutaryl-CoA synthase 2 (HMGCS2)
is an important enzyme involved in cholesterol synthesis.
Long-chain-fatty-acid-CoA ligase 1 (ACSL1) is an important
enzyme in synthesis of fatty acids (Yen et al., 2008). alpha-
methylacyl-CoA racemase (AMACR) is required for the
beta-oxidation of branched-chain fatty acids (Mobley et al.,
2003). Five of eight proteins are Peroxiredoxin-1 (Prdx-1),
superoxide dismutase (SOD1), haemopexin (HPX), 60 kDa
heat shock protein (HSP60), and serine/threonine-protein
phosphatase (CPPED1), all of which are related to lipid
peroxidation and atherosclerosis. The 12 of 20 proteins are
implicated in other metabolic pathways, 5 of 12 proteins are
relevant to amino acid metabolism, S-adenosylmethionine
synthase isoform type-1 (MAT1A) catalyzes the formation of
S-adenosylmethionine from methionine. glutamate-cysteine
ligase regulatory subunit (GCLM) is involved in the sub
pathway that synthesizes glutathione from L-cysteine and L-
glutamate. betaine-homocysteine S-methyltransferase 1 (BHMT)
converts betaine and homocysteine to dimethylglycine and
methionine. carbamoyl-phosphatesynthase (CPS1) catalyzes
the synthesis of carbamoyl phosphate from ammonia and
bicarbonate. sarcosine dehydrogenase (SARDH) catalyzes the
synthesis of formaldehyde and glycine from sarcosine. Three of
twelve proteins are actin (ACTG1), keratin, type I cytoskeletal
18 (KRT18) and tropomyosin alpha-3 chain (TPM3), all of
which are related to cytoskeleton stability. cathepsin B (CTSB)
and proteasome subunit beta type-9 (PSMB9) are related to
protein degradation. ATP synthase subunit alpha (ATP5a1) and
proteasome subunit beta type-9 (PSMB9) are relevant to energy
metabolism. Details of the 20 proteins that showed a ≥1.5-fold
change in density ratio are provided in Figure 4 and Table 3.
DISCUSSION
Hypercholesterolemia and hypertriglyceridemia are important
risk factors that act, either alone, or in combination, to accelerate
the development of cardiovascular disease and the progression
of atherosclerotic lesions (Hun et al., 2007). Thus, reducing
serum TC and/or TG levels are important for atherosclerosis
and cardiovascular disease prevention. High levels of LDL
accumulate in the extracellular subendothelial space of arteries
to form oxidized LDL, which is highly atherogenic and toxic
to vascular cells. It is generally accepted that lowering high
serum LDL levels plays an important role in the prevention and
reversal of atherosclerosis (Haiping et al., 2010). Diet plays a key
role in the control of cholesterol balance, and the consumption
of a high-cholesterol diet is regarded as a crucial risk factor
for the development of hyperlipidaemia. In our study, the rats
ingesting a high-cholesterol diet developed elevated serum levels
of TG, TC, and LDL-C, which were significantly reduced by the
administration of G. frondosa. The results also agreed with those
of previous studies that G. frondosa significantly reduced serum
TG, TC, and LDL-C levels (Kubo andNanba, 1997;Mayumi et al.,
2013). These findings suggest that G. frondosa is a potentially
effective lipid-lowering food. Individuals with hyperlipidemia
could consider using G. frondosa as a dietary supplement for
preventing atherosclerosis and cardiovascular diseases. However,
these studies didn’t elaborate whether the lipid-lowering effects
of G. frondosa are mediated by key genes and proteins involved
in lipid metabolism. Therefore, we investigated its mechanisms
on the hepatic metabolic pathway of lipid by evaluating key
enzyme expression. Furthermore, we elucidated changes in liver
proteomic profiles using 2DE combined with MALDI-TOF-MS.
The inhibition of HMGCR expression leads to suppression
of cholesterol synthesis in liver and further efficiently reduce
serum cholesterol level (Lee et al., 2003). Therefore, HMGCR
is a key target of several widely available cholesterol-lowering
drugs. Statins, currently the most widely used hypolipidaemic
drugs, reduce serum TC levels by inhibiting hepatic HMGCR
expression (Lammi et al., 2015). A quantity of edible mushroom
such as Pleurotus ostreatus, Cratharellus cornucopiodes, Amanita
ponderosa, and particularly Lentinus edodes showed HMGCR
inhibitory capacities ranging from 52 up to 76% in vitro
(Gil-Ramírez et al., 2013). A. auricular significantly decreased
HMGCR activity in mice liver (Chen et al., 2011). Our study
show that G. frondosa potentially capable of down-regulating the
mRNA expression of HMGCR and markedly reduced serum TC
levels in rats. These results showed the inhibitors of HMGCR
represents the most efficient way to reduce serum TC levels.
Accumulation of hepatic cholesteryl esters promote potentially
hyperlipidemia. Tissue-specific knockouts of ACAT2 prevent diet
induced hepatic cholesteryl esters and TC accumulation in the
liver and blood of mice (Zhang et al., 2012). Inhibition of ACAT2
expression may reduce the levels of plasma TC and accumulation
of cholesterol ester on the arterial wall (Bei et al., 2012). In
current study, G. frondosa reduce the accumulation of serum
TC of rats by down-regulating the mRNA expression of ACAT2.
Therefore, the ACAT2-specific inhibitors are effective in treating
or preventing hyperlipidemia. ApoB is an essential component
of LDL and inhibition of ApoB synthesis in the liver may
efficiently reduce the serum LDL. Mipomersen decreases ApoB
synthesis by inhibiting translation of ApoB mRNA (Thomas
et al., 2013). G. frondosa decreased ApoB synthesis by reducing
content of ApoB mRNA and further reduce serum LDL level.
The increase of CYP7A1 expression may enhance catabolic of
cholesterol and thus reduce the serum TC level. L. edodes may
contribute to reducing TC, LDL, TG, hepatic fat accumulation
and aortic atherosclerotic plaque formation by increasing mRNA
expression of CYP7A1 in liver tissues (Yang et al., 2013). In our
study, administration of G. frondosa enhanced CYP7A1 mRNA
expression, resulting in increase of cholesterol conversion into
bile acids.
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TABLE 3 | Identified rat liver proteins.
No. Accession
No.
Gene
name
Protein name Mascot
score
Sequence
coverage
(%)
MW (Da) PI Biological function Protein
expression
(fold change)
1 HMCS2_RAT Hmgcs2 Hydroxy methylglutaryl-CoA
synthase, mitochondrial
96 19 57,332 8.86 This enzyme condenses acetyl-CoA
with acetoacetyl-CoA to form
HMG-CoA, which is the substrate for
HMG-CoA reductase
↓
2 ACSL1_RAT Acsl1 Long-chain-fatty-acid–CoA
ligase 1
253 16 79,155 6.60 Activation of long-chain fatty acids for
synthesis of cellular lipids
↓
3 AMACR_RAT Amacr Alpha-methylacyl-CoA
racemase
126 21 42,201 6.38 This enzyme is required for the
beta-oxidation of branched-chain
fatty acids
↑
4 PRDX1_RAT Prdx1 Peroxiredoxin-1,Prdx-1 239 51 22,323 8.27 Eliminates peroxides generated
during metabolism; elevation of
Prdx-1 levels reduces atherosclerotic
lesion progression
↑
5 SODC_RAT Sod1 Superoxide dismutase
[Cu-Zn]
229 42 16,073 5.88 Destroys radicals normally produced
within the cells which are toxic to
biological systems
↑
6 HEMO_RAT Hpx Hemopexin 215 25 52,060 7.58 Haem binding protein significantly
decreased the activity of lipid
peroxidation
↑
7 METK1_RAT Mat1a S-adenosylmethionine
synthase isoform type-1
201 26 44,240 5.61 Catalyzes the formation of
S-adenosylmethionine from
methionine and ATP
↑
8 BHMT1_RAT Bhmt Betaine–homocysteine
S-methyltransferase 1
265 32 45,404 8.02 Converts betaine and homocysteine
to dimethylglycine and methionine
↑
9 CH60_RAT Hspd1 60 kDa heat shock protein,
mitochondrial
209 15 61,088 5.91 Expression of HSP60 was positively
correlated to the degree of
atherosclerosis, HSP60 may be the
initiating factor for atherosclerosis
↓
10 CPPED_RAT Cpped1 Serine/threonine-protein
phosphatase CPPED1
120 23 35,581 5.40 Inhibitors of serine/threonine protein
phosphatase for treatment or
prevention of arteriosclerotic diseases
↓
11 CPSM_RAT Cps1 Carbamoyl-
phosphatesynthase,
mitochondrial
150 10 1,65,673 6.33 Catalyzes synthesis of carbamoyl
phosphate from ammonia and
bicarbonate
↑
12 SARDH_RAT Sardh Sarcosine dehydrogenase,
mitochondrial
333 23 10,2573 6.15 Sarcosine degradation; synthesizes
formaldehyde and glycine from
sarcosine
↑
13 ACTG_RAT Actg1 Actin, cytoplasmic 2 350 45 42,108 5.31 Actins are highly conserved proteins,
ubiquitously expressed in all
eukaryotic cells
↑
14 K1C18_RAT Krt18 Keratin, type I cytoskeletal
18
355 32 47,732 5.17 When phosphorylated, plays a role in
filament reorganization
↑
15 CATB_RAT Ctsb Cathepsin B 229 23 38,358 5.36 Participates in intracellular
degradation and turnover of proteins
↑
16 ATPA_RAT Atp5a1 ATP synthase subunit alpha,
mitochondrial
356 27 59,831 9.22 Mitochondrial membrane ATP
synthase (F1F0 ATP synthase or
complex V) produces ATP from ADP
↑
17 PSB9_RAT Psmb9 Proteasome subunit beta
type-9
100 24 23,424 4.88 Cleavage of peptide bonds with very
broad specificity
↑
18 TPM3_RAT Tpm3 Tropomyosin alpha-3 chain 210 39 29,217 4.75 Binds to actin filaments in cells; in
non-muscle cells, is implicated in
stabilizing cytoskeleton actin filaments
↓
19 GSH0_RAT Gclm Glutamate–cysteine ligase
regulatory subunit
127 24 30,871 5.36 Involved in the sub-pathway that
synthesizes glutathione from
L-cysteine and L-glutamate
↓
20 CYB5_RAT Cyb5a Cytochrome b5 248 34 15,346 4.90 Electron carrier for several
membrane-bound oxygenases
↓
↑: Protein expression up-regulated in control and G. frondosa groups compared with the hyperlipidemic group.
↓: Protein expression down-regulated in control and G. frondosa groups compared with the hyperlipidemic group.
Frontiers in Microbiology | www.frontiersin.org 7 August 2016 | Volume 7 | Article 1186
Ding et al. Hypolipidaemic Effects of Grifola frondosa
FIGURE 5 | Lipid metabolism in rat liver. : mRNA expression, enzymatic concentration up-regulated in Grifola frondosa group compared with the hyperlipidemic
group. : mRNA expression, enzymatic concentration down-regulated in G. frondosa group compared with the hyperlipidemic group. : Protein expression
up-regulated in G. frondosa group compared with the hyperlipidemic group; : Protein expression down-regulated in G. frondosa group compared with the
hyperlipidemic group.
Cholesterol homeostasis is regulated by well-balanced
mechanisms controlling mRNA encoding multiple enzymes
(Kenichiro et al., 2005). The concentrations of these enzymes
in the present study also paralleled the observed changes in
mRNA levels. Down-regulation of HMGCR, ACAT2, and ApoB
mRNA expression by administering G. frondosa reduced the
concentration of these enzymes and may have resulted in the
decreased serum TC and LDL levels. Conversely, up-regulation
of CYP7A1 mRNA expression by administering G. frondosa
increased concentration of the enzyme and may promote the
conversion of cholesterol to bile acid, thus reducing serum TC
levels. Therefore, cholesterol-lowering effects of G. frondosa
are regulated by down-regulation of HMGCR, ACAT2, and
ApoB and up-regulation of CYP7A1 levels, which inhibited the
synthesis, absorption and transport of cholesterol, and enhanced
its catabolism.
Accumulation of TG in hepatocytes is associated with
metabolic disorder (Fatiha et al., 2013). ACC1 is a key
rate-limiting enzyme in synthesis of fatty acids and TG
in the liver. ACC1 catalyzes the carboxylation of acetyl-
CoA to form malonyl-CoA, while FAS catalyzes palmitate
formation (Menendez et al., 2009). The inhibition of ACC1
expression will limit TG de novo synthesis and further
reduce serum TG levels. Gemfibrozil, currently widely used
hypotriglyceridemic drugs, reduce serum TG levels by inhibiting
hepatic ACC1 expression. We found significant reductions in
the mRNA expression levels and concentration of FAS and
ACC1 in rats treated with G. frondosa, as well as lower
serum TG levels. Consequently, G. frondosa may inhibit
FAS and ACC1 expression to produce beneficial effects in
hypertriglyceridaemia, thus reducing serum TG and risk of
cardiovascular disease.
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To further investigate the influence of G. frondosa on
liver lipid metabolism, we employed proteomic tools (2-DE
and MALDI-TOF-MS) to globally identify proteins that were
differentially expressed in the livers of rats administered with
G. frondosa compared with untreated hyperlipidemic rats. Our
proteomic data revealed that 20 proteins were differentially
expressed between the two groups. Interestingly, HMGCS2
is relevant synthesis of cholesterol and condenses acetyl-CoA
with acetoacetyl-CoA to form 3-hydroxy-3-methylglutaryl-CoA
(HMGC), which is the substrate for HMGCR. HMGCR is a key
rate-limiting enzyme in cholesterol synthesis and catalyzes the
production of mevalonic acid from HMGC. Down-regulation of
HMGCS2 protein expression (Table 3) may inhibit cholesterol
biosynthesis and further decrease serum TC levels. The marked
reduction in serum TC levels observed in rats administered G.
frondosa could be explained by the down-regulation of HMGCS2
protein expression. Among the 20 identified proteins, ACSL1 and
AMACR are of interest with respect to fatty acid metabolism.
ACSL1 catalyzes the conversion of free fatty acids to acyl–CoA
and the reaction of acyl–CoA with diacylglycerol to form TG.
Similar investigations (Ying-Ling et al., 2014) showed that toll-
like receptor agonists promote prolonged TG storage in murine
and human macrophages by enhancing fatty acid uptake and
increasing TG synthesis, with an associated persistent increases in
ACSL1. Therefore, down-regulation of ACSL1 protein expression
could inhibit fatty acid biosynthesis. The other protein, AMACR,
is required for oxidation of fatty acids (Mobley et al., 2003),
and it’s up-regulation could enhance catabolism of fatty acids.
The inhibition of ACSL1, required for fatty acid biosynthesis,
and the increase in AMACR, involved in fatty acid catabolism,
could therefore result in decreased fatty acid content and further
decrease serum TG levels in rats treated with G. frondosa.
High levels of LDL are present in the vessel walls, and LDL
undergoes oxidative attack by reactive oxygen species (ROS) to
generate oxidized LDL (oxLDL). Endothelial cell dysfunction and
the accumulation of oxLDL in the vessel wall are early events
in atherogenesis, resulting in the recruitment of circulating
monocytes, their adhesion to the endothelium, their subsequent
differentiation into macrophages, and the accumulation of
oxLDL to form foam cells. Therefore, oxLDL plays a pivotal
role in the initiation and promotion of atherosclerosis (Augusti
et al., 2012), and lowering oxLDL levels represents an important
strategy for the treatment and prevention of atherosclerosis.
SOD and Prdx-1 both are member of a ubiquitous family
of antioxidant enzymes that reduces oxLDL levels and early
atherosclerosis. SOD destroys radicals that are toxic to biological
systems. Tea polyphenols may confer anti-atherosclerotic effects
by inhibiting oxidation of LDL by SOD (Uto-Kondo et al.,
2013). The elevated Prdx-1 level associated with T-cell death-
associated gene 51 deficiency contributes to increased resistance
to oxidative stress, leading to reduce atherosclerotic lesion
growth in mice (Hossain et al., 2013). HPX has a strong binding
capacity to haem and thus can transport free toxic haem.
HPX also exhibits anti-oxidant, immune regulation, and organic
protection effects. When bound to HPX, haem significantly
reduced oxygen free radical levels and decreased the catalytic
activity of lipid peroxidation (oxLDL) (Grinberg et al., 1999).
Therefore, up-regulation of SOD1, Prdx-1, and HPX expression
can increase resistance to oxLDL formation, thereby reducing
atherosclerotic lesion progression. CPPED1 dephosphorylates
AKT (protein kinase B) family kinases, specifically at Ser-473.
Studies (Vaittinen et al., 2013) demonstrated that knockdown of
CPPED1 expression enhances insulin-stimulated glucose uptake
in mature adipocytes, leading to improved glucose metabolism
via adiponectin-mediated mechanisms. The results (Walter,
2006) indicated that inhibitors of CPPED1 may be useful
for the treatment or prevention of arteriosclerotic diseases.
These results showed down-regulation of CPPED1 expression
prevent arteriosclerotic disease. In response to free radicals
and oxidative stress, cells produce high levels of HSP60.
Studies (Yu et al., 2013) showed that Porphyromonas gingivalis
challenge increased the expression of oxidative stress-related
mediators, such as CCL2 and HSP60. In contrast, consumption
of green tea epigallocatechin-3-gallate decreased atherosclerotic
lesions and oxidative stress-related mediators in atherosclerotic
mice induced by P. gingivalis. Overall, down-regulation of
CPPED1, and HSP60 reduces atherosclerotic lesion progression.
To summarize, we showed that G. frondosa produced anti-
atherosclerotic effects by inhibiting LDLox formation via a
reduction CPPED1 and HSP60 levels and increased levels of
SOD1, Prdx-1, and HPX in rat liver.
Eight of the 20 proteins identified were relevant to lipid
metabolism. The remaining 12 proteins are implicated in other
metabolic pathways,MAT1A, GCLM, BHMT, CPS1, and SARDH
are relevant to amino acid metabolism. MAT1A form S-
adenosylmethionine (SAM), which is precursor of glutathione
(GSH). GCLM is an important enzyme in synthesis of GSH,
which has antioxidation effect. Therefore, MAT1A and GCLM
indirectly involved in lipid peroxidation. ACTG1, KRT18, and
TPM3 keep cytoskeleton stability to provide support frame for
lipid metabolism. CTSB and PSMB9 degrade excess lipoprotein
in cell. ATP5a1 and Cyb5a provide energy for lipid metabolism.
CONCLUSIONS
G. frondosa exerted hypolipidaemic and anti-atherosclerotic
effects in this study. Figure 5 shows the hypolipidaemic effects
of G. frondosa through down-regulation of HMGCR, HMGCS2,
ACAT2, and ApoB and up-regulation of CYP7A1 expression
levels of mRNA or proteins involved in cholesterol biosynthesis,
absorption, catabolism. Furthermore, G. frondosa down-
regulated FAS, ACC1, and ACSL1 and up-regulated AMACR
expression levels of mRNA or proteins involved in triacylglycerol
biosynthesis and catabolism. The anti-atherosclerotic effects of
G. frondosa can function through the inhibition of LDL oxidation
by down-regulated HSP60 and CPPED1 and up-regulated Prdx-
1, SOD1, and HPX expression levels in rat liver. These findings
indicate that G. frondosa has significant potential as a functional
food to treat or prevent hyperlipidaemia and atherosclerosis.
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